Therefore, further investigation of GPC1 expression in different CAF subtypes is warranted as well as whether our GPC1-specific CAR T cells could re-model the tumor microenvironment and destroy GPC1-positive pancreatic cancer cells. This evidence concerns the gene GPC1 and pancreatic neoplasm.